The forefront of analysis and purification of nucleic acid medicines and mRNA - from oligonucleotides, mRNA, to LNP.

Oligonucleotides are attracting attention as a particularly interesting field, with a high potential to lead to the treatment of various diseases, and are expected to have promising prospects in biopharmaceutical development. These oligonucleotides cover a wide range in terms of size, sequence complexity, and overall modifications. They encompass mRNA and lipid nanoparticles. We will introduce the challenges and solutions related to the analysis and purification of nucleic acid drugs, mRNA, and LNPs.
Date: May 20, 2025 (Tuesday) 15:00-16:00
Target Participants:
- Individuals engaged in research and development, manufacturing, quality control, and contract work related to nucleic acid drugs, mRNA, and LNPs.
- Those wishing to quickly acquire a basic understanding of the characterization of biopharmaceuticals and mid-sized molecular drugs.
- Researchers, universities, government agencies, and ventures interested in the separation and purification of biopharmaceuticals.
- Individuals interested in the automation and labor-saving of the transfer from the purification and analysis of oligonucleotides and mRNA.
Program:
- "Introduction to Agilent's Bio Columns and Consumables Useful for the Characterization of Nucleic Acid Drugs"
- "Challenges and Solutions in the Purification and Analysis of Oligonucleotides"

Date and time | Tuesday, May 20, 2025 03:00 PM ~ 04:00 PM |
---|---|
Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration